Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Stadler

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
The British Journal of Dermatology|August 12, 2025
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, Chalid Assaf, Martine Bagot, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departmentsNina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia J Scarisbrick, H Miles Prince, Maarten H Vermeer, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
The British Journal of Dermatology|August 12, 2025
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, Chalid Assaf, Martine Bagot, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departmentsNina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia J Scarisbrick, H Miles Prince, Maarten H Vermeer, et al.
Pageof 15